Pulmonary Diseases CEU Courses for Respiratory Therapists

This course provides both a physiologic overview as well as evidence-based considerations of cardiovascular disease management in respiratory care. The course is designed to provide the listener with additional perspective in the critical care of patients with cardiovascular comorbidity.

This course focuses on the progression of "long COVID of the lungs," identifying current post-acute sequelae of the SARS-CoV-2 infection (PASC) involving the lungs with special focus on pulmonary fibrosis. The course reviews evidence-based literature on diagnosis and treatment intervention and post-COVID-19 initiatives for best practice management of pulmonary PASC.

New treatments for COPD have emerged for patients with emphysema and chronic bronchitis. This course provides an overview of these new therapies and where they may be applied now and in the future.

This lecture covers common and current practice as it pertains to the support of critically ill patients with COVID-19 and COVID-related Acute Respiratory Distress Syndrome (CARDS). The topics discussed are supported by the literature and evidence.

Patients with Acute Respiratory Distress Syndrome (ARDS) and tracheostomy are a widely heterogeneous and complex group of patients who are at risk for infection, medical complications, and dysphagia. This course examines the mechanisms of swallow dysfunction in patients with ARDS and tracheostomy and explores the impact of dysphagia on disease management, weaning, and decannulation, and respiratory function.

Patients with Chronic Obstructive Pulmonary Disease (COPD) or Obstructive Sleep Apnea (OSA) present with considerable disease burdens that impact clinical outcomes and quality of life. This course examines the mechanisms of swallow dysfunction in patients with COPD and OSA and explores the impact of aspiration on lung health, disease exacerbation, and respiratory function.

Cystic Fibrosis is a complex diagnosis that affects multi-organ systems and requires management and care from a multidisciplinary team. This webinar addresses pathophysiology, diagnosis, management of pulmonary and non-pulmonary symptoms. Current and emerging cystic fibrosis therapies are discussed.

Pediatric asthma diagnosis is on the rise, and patient families are looking for information about boosting their health to rely less on expensive conventional medicine. This course provides respiratory therapists with a general overview of pediatric asthma and tools of motivational interviewing counseling to enhance the overall quality of life in pediatric patients in both acute and post-acute care settings.

The course introduces an Acute Respiratory Distress Syndrome (ARDS) survivor perspective explaining how education and advocacy of resources positively affect patient-centered care. The course presents current ARDS and COVID-19 evidence and disease impact on managing critically ill patients.

This course focuses on the pharmacokinetics and pharmacodynamics of general respiratory drug agents. Classification, mechanism of action, and therapeutic effects are discussed.